LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 1884 | 1290 | 1.4602 | 1.1254 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 1549 | 1466 | 1.0561 | 1.0171 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 1618 | 1466 | 1.1031 | 1.0309 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 543 | 1466 | 0.3702 | 0.7128 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 1429 | 1466 | 0.9743 | 0.9919 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 2 | 1466 | 0.0014 | -0.2855 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 2136 | 1466 | 1.4563 | 1.1208 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 26.70 | 17.25 | 2020 | 1466 | 1.3772 | 1.1024 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 1695 | 1653 | 1.0253 | 1.0076 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 1787 | 1653 | 1.0810 | 1.0238 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 773 | 1653 | 0.4676 | 0.7819 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 1611 | 1653 | 0.9745 | 0.9922 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 2312 | 1653 | 1.3985 | 1.1046 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 28.67 | 17.25 | 2224 | 1653 | 1.3453 | 1.0922 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 1872 | 1887 | 0.9918 | 0.9976 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 1962 | 1887 | 1.0395 | 1.0115 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 897 | 1887 | 0.4753 | 0.7920 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 1772 | 1887 | 0.9388 | 0.9815 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 2548 | 1887 | 1.3500 | 1.0906 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | H15 |